News & Press Releases

Meet our senior advisor Kerstin Jakobsson at the Nordic Life Science Days at Bella Center in Copenhagen

Patent application for our Digital Twin Software Platform

New visiting adress – Close to the new proton therapy facility

Financing for the clinical evaluation of MaMa-K was secured

New CEO and chairman of Kongsberg Beam Technology AS

Trondheim Tech Port-conference 20 March 2023

Kongsberg Beam Technology has been awarded second prize in the pitching session at Norway Life Science 2023

Kongsberg Beam Technology selected to pitch at the DNB Nordic Healthcare Conference 2022

Kongsberg Beam Technology attending the EHiN 2022 conference

Open position- project employee

Kongsberg Beam Technology appoints Stephan Dymling as new Chief Technology Officer

We are attending the LSX Nordic Congress September 6-7


Interview with CEO Per Håvard Kleven by the Norwegian Cancer Patient Association 

Read the interview (only in Norwegian)

Skal hente opptil 20 millioner kroner

Article online

Skuddpremie på bivirkninger

PDF file

Experienced CEO joins Kongsberg Beam Technology

Kongsberg Hentet inn 13 millioner

Kreftceller i sikte

Studying medtech with cancer patients at heart

Article online

Semcon responsible for development of revolutionary cancer treatment

Article online

Fikk 22,7 millioner av Forskningsrådet

Skal drepe kreftceller mer effektivt med industriell ammunisjon

Article online

Per Håvards idé kan bli verdensnyhet



About Kongsberg Beam Technology
Kongsberg Beam Technology strives to become a premier partner for leading companies within the radiation therapy industry. Based on its AI-supported software solution, MaMa-K™ can substantially enhance the performance and safety of established treatment equipment and dose-planning systems. MaMa-K makes it possible to monitor and predict anatomical and functional changes of a tumour and surrounding tissue, e.g. organs at risk, between treatment sessions. The MaMa-K software will further allow real-time optimisation of delivered radiation. With these unique properties, MaMa-K has the potential to significantly improve treatment outcomes and limit severe short- and long-term side effects.

Images for download

Kerstin Jakobsson

Senior Advisor

Per Håvard Kleven

CEO and founder

Logotypes for download